It’s Monday, November 3, 2025, and we’re back with the top startup and tech funding news stories making wes today. From billion-dollar AI bets to robotics, agtech, and deep-tech breakthroughs, investors showed no signs of slowing down as capital poured into both late-stage powerhouses and ambitious early-stage disruptors.
Today’s highlights feature Hippocratic AI, which raised $126 million at a $3.5 billion valuation to expand its patient-facing healthcare AI agents; General Intuition, which launched with a massive $133.7 million seed round to pioneer spatial-temporal AI agents; and Aantgarde Bio, which secured $141 million to advance its gene therapy platform for inherited retinal diseases. The momentum extended across verticals — from autonomous robotics and cloud security to AI-driven agriculture and neuro-symbolic computing — underscoring investor confidence in frontier innovation.
Funding HighlightsHippocratic AI raised $126 million in Series C funding to scale its healthcare AI assistant network and accelerate clinical deployments.
Aantgarde Bio secured $141 million in Series B funding to expand its gene therapy pipeline for rare diseases.
General Intuition launched with a $133.7 million seed round to develop spatial-temporal AI agents trained on massive gaming datasets.
Infrision raised $91 million in Series B funding to scale its aerial robotics platform for power-line construction and maintenance.
Source.ag closed a €15.2 million (~$16.3 million) growth round to expand its AI-driven greenhouse management software to 18 countries.
Teleskope brought in $25 million in Series A funding to enhance AI data pipeline security across cloud systems.
Mimic Robotics raised $16 million in seed funding to commercialize its dexterous robotic hands platform.
Magic raised $10 million in seed funding to bring AI-powered personalization to hospitality and retail.
SecurePII closed a $3.5 million seed round to protect voice data privacy for enterprise communications.
Augmented Intelligence Inc. (AUI) raised $20 million in SAFE at a $750 million valuation cap for neuro-symbolic AI models.
OpenMind received a strategic investment from Pi Network Ventures to expand its open-source robot OS platform.
Investor ActivityToday’s rounds drew participation from some of the world’s most active venture backers — including General Catalyst, Andreessen Horowitz, RTW Investments, Khosla Ventures, and M13 — highlighting strong conviction in AI infrastructure, deep-tech, and automation. Early-stage funds such as Speedinvest, Lerer Hippeau, and Astanor Ventures continued to anchor seed and growth rounds across the U.S. and Europe, signaling a healthy deal flow across the global innovation landscape.
Together, these financings underscore a robust start to November — with AI, healthcare, robotics, and data security startups leading the charge toward a new we of technological transformation.
Here’s the full breakdown. Until tomorrow, he a great evening.
Hippocratic AI Raises $126M in Series C Funding at $3.5B Valuation
Hippocratic AI, a health technology startup building patient-facing AI agents, has secured $126 million in Series C funding to expand its suite of clinical and administrative tools for hospitals and insurers. The company’s AI models are designed to safely handle sensitive patient interactions, offering a scalable alternative to traditional telehealth triage systems.
This round pushes Hippocratic AI’s valuation to $3.5 billion, reflecting investor confidence in AI’s role in healthcare. The company plans to use the fresh capital to accelerate clinical trials, pursue regulatory approvals, and expand into new markets across North America and Europe.
Founded by CEO Munjal Shah, along with a group of physicians, hospital administrators, and AI researchers from institutions such as El Camino Health, Johns Hopkins, Stanford, Microsoft, Google, and NVIDIA, Hippocratic AI is developing generative AI agents for healthcare. The startup has already partnered with more than 50 healthcare organizations, including Cleveland Clinic, Northwestern Medicine, Ochsner Health, Moffitt Cancer Center, and University Hospitals.
Funding Details:
Startup: Hippocratic AI
Investors: General Catalyst (lead), Andreessen Horowitz, Premji Invest, and SV Angel
Amount Raised: $126 million
Total Raised: Over $230 million
Funding Stage: Series C
Funding Date: November 3, 2025
Infrision Secures $91M in Series B Funding to Scale Aerial Robotics for Power LinesInfrision, an Austin-based aerial robotics company, raised $91 million in Series B funding to transform how power lines are built and maintained. Its drone-enabled technology streamlines powerline stringing and inspection, offering a faster, safer, and more sustainable alternative to traditional methods.
The new funding will support Infrision’s global expansion and the development of autonomous deployment systems for utility-scale projects. As global demand for grid infrastructure modernization grows, the company aims to reduce operational costs while accelerating clean energy transmission.
Funding Details:
Startup: Infrision
Investors: Energy Impact Partners (lead), SE Ventures, and Equinor Ventures
Amount Raised: $91 million
Total Raised: $114 million
Funding Stage: Series B
Funding Date: November 3, 2025
Aantgarde Bio Closes $141M in Series B Funding for Gene Therapy InnovationItaly-based biotech Aantgarde Bio has closed a $141 million Series B round to advance its next-generation gene therapy platform aimed at treating inherited retinal diseases. The company’s proprietary A-based technology enables the delivery of large or multiple genes that cannot fit within traditional viral vectors.
The capital will fund ongoing clinical trials and support the expansion of its ophthalmology and neurology pipeline. With the new investment, Aantgarde Bio aims to become a global leader in gene therapy development, targeting conditions previously considered untreatable.
Funding Details:
Startup: Aantgarde Bio
Investors: RTW Investments (lead), Forbion, and Sofinnova Partners
Amount Raised: $141 million
Total Raised: $190 million
Funding Stage: Series B
Funding Date: November 3, 2025
Teleskope Raises $25M in Series A Funding to Redefine AI Data SecurityTeleskope, a New York-based data security startup, raised $25 million in Series A funding to expand its platform that protects sensitive data across cloud environments. The company provides visibility and compliance tools for AI data pipelines, ensuring enterprises maintain control over customer and proprietary datasets.
The funding will enable Teleskope to accelerate product development and broaden its partnerships with cloud providers. With growing regulatory focus on AI safety, the company’s platform is gaining traction among Fortune 500 clients and government agencies alike.
Funding Details:
Startup: Teleskope
Investors: M13 (lead), Lerer Hippeau, and Craft Ventures
Amount Raised: $25 million
Total Raised: $30 million
Funding Stage: Series A
Funding Date: November 3, 2025
Source.ag Raises €15.2M in Funding to Expand AI Software for Greenhouse FarmingDutch agtech company Source.ag has secured €15.2 million ($16.3 million) in funding to scale its AI-driven software that helps greenhouse farmers optimize crop yields and resource efficiency. The company’s platform analyzes data from sensors and climate systems to provide real-time growing recommendations for fruits and vegetables.
This funding will accelerate Source.ag’s expansion to over 18 countries and help onboard hundreds of new farms. With agriculture facing mounting pressure to produce more with less, the company’s technology is seen as a key driver in sustainable food production.
Funding Details:
Startup: Source.ag
Investors: Astanor Ventures (lead), RedAlpine, and E14 Fund
Amount Raised: €15.2 million ($16.3 million)
Total Raised: $60 million
Funding Stage: Growth Round
Funding Date: November 3, 2025